EyePoint Pharmaceuticals
EYPT
EYPT
42 hedge funds and large institutions have $15M invested in EyePoint Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 10 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
2.56% more ownership
Funds ownership: 0% → 2.56% (+2.6%)
50% less capital invested
Capital invested by funds: $29.9M → $15M (-$14.9M)
Holders
42
Holding in Top 10
–
Calls
$433K
Puts
$31K
Top Buyers
| 1 | +$393K | |
| 2 | +$226K | |
| 3 | +$225K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$215K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$55K |
Top Sellers
| 1 | -$1.85M | |
| 2 | -$1.33M | |
| 3 | -$466K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$445K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$86K |